205 related articles for article (PubMed ID: 17126841)
1. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
[TBL] [Abstract][Full Text] [Related]
2. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
3. Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Panfilov VI
Chest; 2007 Jul; 132(1):120-6. PubMed ID: 17475630
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history.
Wang CP; Hung WC; Yu TH; Chiu CA; Lu LF; Chung FM; Hung CH; Shin SJ; Chen HJ; Lee YJ
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):346-52. PubMed ID: 20140850
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.
Spiecker M; Liao J
Trends Cardiovasc Med; 2006 Aug; 16(6):204-8. PubMed ID: 16839864
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
Liu PY; Chen JH; Li YH; Wu HL; Shi GY
Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
[TBL] [Abstract][Full Text] [Related]
7. The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.
Börgel J; Bulut D; Hanefeld C; Neubauer H; Mügge A; Epplen JT; Holland-Letz T; Spiecker M
BMC Cardiovasc Disord; 2008 Dec; 8():41. PubMed ID: 19105833
[TBL] [Abstract][Full Text] [Related]
8. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
[TBL] [Abstract][Full Text] [Related]
9. A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China.
Zhu Q; Fu Z; Ma Y; Yang H; Huang D; Xie X; Liu F; Zheng Y; Cha E
Clin Biochem; 2013 Aug; 46(12):1047-1054. PubMed ID: 23684773
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus.
Pucci L; Lucchesi D; Chirulli V; Penno G; Johansson I; Gervasi P; Del Prato S; Longo V
Am J Pharmacogenomics; 2003; 3(5):355-8. PubMed ID: 14575523
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
[TBL] [Abstract][Full Text] [Related]
13. A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Ivakin VE; Katargina LN; Kolesnikova OE
Dis Markers; 2008; 24(2):119-26. PubMed ID: 18219097
[TBL] [Abstract][Full Text] [Related]
14. CYP2J2*7 single nucleotide polymorphism in a Chinese population.
Wang H; Jiang Y; Liu Y; Lin C; Cheng G; Chen X; Hao B; Tan W; Lin D; He F
Clin Chim Acta; 2006 Mar; 365(1-2):125-8. PubMed ID: 16182271
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
Jiang JG; Chen CL; Card JW; Yang S; Chen JX; Fu XN; Ning YG; Xiao X; Zeldin DC; Wang DW
Cancer Res; 2005 Jun; 65(11):4707-15. PubMed ID: 15930289
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome p450 epoxygenase promotes human cancer metastasis.
Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-specific CYP2J2 overexpression improves cardiac dysfunction by promoting angiogenesis via Jagged1/Notch1 signaling.
Zhao Q; Huang J; Wang D; Chen L; Sun D; Zhao C
J Mol Cell Cardiol; 2018 Oct; 123():118-127. PubMed ID: 30219518
[TBL] [Abstract][Full Text] [Related]
19. CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population.
Yan H; Kong Y; He B; Huang M; Li J; Zheng J; Liang L; Bi J; Zhao S; Shi L
Neurosci Lett; 2015 Apr; 593():56-60. PubMed ID: 25796175
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.
Li YH; Chen JH; Tsai WC; Chao TH; Guo HR; Tsai LM; Wu HL; Shi GY
Thromb Haemost; 2002 Jan; 87(1):86-91. PubMed ID: 11848462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]